ORCL Form 4: Stuart Levey Receives RSUs and Sells 12,405 Shares at $292.18
Rhea-AI Filing Summary
Stuart Levey, EVP and Chief Legal Officer of Oracle Corporation (ORCL), reported multiple transactions on 09/15/2025. He was granted 26,337 restricted stock units (RSUs) that represent the right to receive one share each at settlement, increasing his RSU holdings to 52,674 underlying shares after the grant. On the same date he disclosed the disposition of 12,405 shares in an open-market sale at an average price of $292.18, leaving him with 27,547 shares owned directly. The RSUs vest in four equal annual installments beginning one year after grant. Shares were withheld to satisfy tax withholding upon vesting as noted in the filing. The form was signed by a power of attorney on behalf of Mr. Levey.
Positive
- Received 26,337 RSUs which align executive compensation with shareholder interests through equity-based awards
- RSUs vest over four years, providing retention incentives and staged issuance rather than immediate dilution
Negative
- Disposition of 12,405 shares at an average price of $292.18 reduced direct holdings to 27,547 shares
- Potential future dilution of 26,337 shares when RSUs vest and settle
Insights
TL;DR: Officer disclosed a routine combination of equity compensation grant and share sale; vesting schedule creates future share issuance.
The filing shows a standard compensation-related equity grant of 26,337 RSUs with a four-year annual vesting schedule, which will translate into incremental share issuance over the next four years as units vest. The contemporaneous sale of 12,405 shares at $292.18 is recorded as a disposition reducing direct holdings to 27,547 shares. Both transactions are typical for senior executives managing compensation and tax obligations. The use of a power of attorney for filing is noted and acceptable procedure.
TL;DR: Transactions are disclosure of executive compensation and a partial share sale; not immediately material to company fundamentals.
The grant of RSUs increases potential future dilution by 26,337 shares subject to vesting; the filing specifies withholding of shares for tax purposes. The reported open-market sale of 12,405 shares at $292.18 provides an exact realized price but does not, by itself, indicate a change in company outlook or performance. Impact on share count and outstanding dilution should be tracked as RSUs vest and settle.